Current Members

Photos: Fang EF lab, Birgit Solhaug (UiO), or private.

Evandro Fei Fang (Fang-Stavem), Ph.D. (CUHK), Professor of Gerontology and Neuroscience, Academician of the Norwegian Academy of Science and Letters (DNVA, 挪威科學與文學院院士), PI (2017.10-present)
Email: evandrofeifang [at] yahoo.com; e.f.fang [at] medisin.uio.no
Evandro F. Fang is the Professor of Gerontology and Neuroscience at the University of Oslo (UiO) and the Akershus University Hospital, Norway, and his group are working on the molecular mechanisms of human ageing and age-predisposed neurodegeneration (https://evandrofanglab.com/). More specifically, the Fang laboratory is focusing on the molecular mechanisms behind how cells clear their damaged and aged mitochondria, a process termed “mitophagy”, as well as the roles of the NAD+-mitophagy/autophagy axis in healthy ageing and AD inhibition. NAD+ is a fundamental molecule in life and health and decreases in ageing and AD. Dr Fang is fascinated with and actively engaged in moving his laboratory findings to translational applications and is involved in several NAD+-based clinical trials, with the overarching goal of establishing novel and safe biological approaches to promote longer and healthier human lives. As a Clarivate Highly Cited Researcher 2025 (1‰; and one of 22 in Norway), he has published over 150 papers in international peer-reviewed journals including papers in Cell, Cell Metabolism, Nature Reviews MCB, Nature Neuroscience, Nature Ageing, Nature Biomedical Engineering, and Lancet Healthy Longevity. He routinely reviews grants for more than 30 leading foundations, including European Research Council (ERC, EU), Medical Research Council (MRC, UK), and AFAR (USA). He has been associate Editor-in-Chief (Deputy Editor) of 4 leading ageing journals, including Ageing Research Reviews, Mechanisms of Ageing and Development, npj Ageing, and Journal of Gerontology: Biological Section. He has received several awards including the Butler-Williams Scholar on Aging 2016 by NIA (USA), the ‘Scientific Award to Young Scientist in the Natural Sciences for 2020 by The Royal Norwegian Society of Sciences and Letters (Norway), and the 2023 Norwegian National Dementia research award of the National Association for Public Health presented by H.M. King Harald V of Norway. After finishing his PhD at the Chinese University of Hong Kong, he had a 6-year postdoc training with Prof. Vilhelm Bohr on molecular gerontology and Prof. Mark Mattson on neuronal resilience in Alzheimer’s disease at the National Institute on Ageing, Baltimore. He opened his lab in Oslo in the fall of 2017. He is the founding (co)coordinator of the Norwegian Centre on Healthy Ageing network (NO-Age, www.noage100.com), the Norwegian National anti-Alzheimer’s disease Network (NO-AD, www.noad100.com), and the Hong Kong-Nordic Research Network. He sits in the expert roundtable on aging research for the United Nation’s Scientific Advisory Board.
Hobbies: Badminton; Soccer; Hiking; Gardening and farming.

Thale Dawn Patrick-Brown, MSc, MIET, PPT, Lab manager (part-time, 2021.03-)
Email: thale [at] orthrus.no
Thale started her research career last century at the precocious age of 12, when she took up her first post as a summer research assistant, pulling catheters, packing and autoclaving surgical equipment, and assisting with things requiring small fingers. Eventually, she graduated from lower school and obtained an honours degree in Neuroscience studying under the profs who literally wrote the book (Kolb and Whishaw), who likely only remember her as that lass whose senior project proposed a neural network for diagnosis of psychiatrically-relevant changes in the brain using fMRI before such things were computationally possible (she got a D). Thale completed an eye-watering three full undergraduate theses in Foetal Physiology, Aerospace Neurophysiology, and 11-Beta Hydroxysteroid Dehydrogenase Type 1&2 in foetal development respectively. Thale recently published a paper describing a novel statistical methodology for the estimation of prevalence and incidence in rare diseases using Pseudomyxoma peritonei (PMP) as a model. She has undertaken specialist training in gross anatomy and is interested in the role of the HPA axis in physiological activities, including parturition and metastatic disease. Thale is a professional medical project manager and can usually be found staring intently at a computer screen, muttering incoherently about grammar.
Interests:
Thale is a licensed race driver and sports therapist, plays polo and is terminally British.

Sofie H. Lautrup, Ph.D. (Aarhus University, Denmark), Senior Postdoc Fellow (2018-present)
Email: s.h.lautrup [at] medisin.uio.no
Dr. Sofie Lautrup is a founding member and a postdoc fellow in the Fang lab. During her PhD program, she studied the connections between the DNA repair pathway base excision repair (BER) and cognitive capacity during aging and disease, under the supervision of Associated Professor Tinna Stevnsner at Aarhus University, Denmark. In addition, she has worked with premature aging by characterising two Danish patients suffering from Cockayne Syndrome (MAD 2018). Dr Lautrup also worked in the laboratory of Dr Vilhelm A. Bohr at National Institute on Aging, Baltimore, USA during her PhD programme. At NIA, she jointly examined the effect of treatment with the NAD+ precursor Nicotinamide Riboside (NR) on different Alzheimer’s disease (AD) mouse models, including a DNA repair deficient AD mouse model (PNAS, 2018, 2021). In the Fang laboratory, she explores mechanisms of both biological ageing and the age-predisposed AD. For biological ageing, she uses both normal ageing and premature ageing models to study the underlying mechanisms focusing on compromise of the NAD+-mitophagy axis. For AD, she explores molecular mechanisms of selective neuronal vulnerability in AD by dissecting the intertwined relationships between autophagy and ferroptosis. She has authored/co-authored over 30 publications, including papers in Cell Metabolism (2019), Nature Biomedical Engineering (2022), Nature Ageing (2025), Nature Ageing (2026), as well as Alzheimer&Dementia (2026).
Hobbies: Hiking/exploring the nature, being a scout, hanging out with friends/family.

Janet Jian-ying Zhang, Ph.D. (Sun Yat-sen University, China), Postdoc Fellow (2021.02-present)
Email: zhjianying [at] gmail.com
Dr Zhang got her PhD degree in Clinical Science of Stomatology from Sun Yat-sen University, China in 2016. After graduation, she became a licensed dentist in China, while working as a researcher at Central South University. Dr Zhang is fascinated with observing the progression of life from tiny cells up to a well crafted tooth via all kinds of experimental microscopies as well as her favorite dental operating microscope. In the Fang lab, Dr Zhang is devoted to unveiling the causes of delirium and how it progresses to Alzheimer’s disease via examination of several possible molecular mechanisms. She was the 2026 recipient of the prestigious nasjonalforeningen for folkehelsen postdoc fellowship. Among many publications in the Fang lab, a recent one was a commissioned review paper on NAD+ for Nature Ageing (Emerging strategies, applications and challenges of targeting NAD+ in the clinic – PubMed), jointed with He-Ling Wang and other co-authors.
Hobbies: Travel, gourmet lover, work out

Shuqin Cao, visiting Ph.D candidate (2020.02-2022.01), Postdoc Fellow (2022.02-present)
Email: queenaqin27 [at] gmail.com
Shu holds a bachelor degree from The University of Malaya, Malaysia, and did a PhD programme in Clinical Biochemistry and Molecular Medicine at the Chulalongkorn University, Thailand. She was working as a visiting student in the Fang lab (UiO) from Feb 2020 to Jan 2022 and finished her PhD thesis in the Fang lab and defended her PhD in Oslo via zoom. Her oral defense (viva voce) was entitled ‘Neuroprotective effects of Passiflora Edulis Sims against amyloid beta-induced neurotoxicity’. In her postdoc programme, she is continuing in depth characterization of a few novel mitophagy inducers she has identified during her PhD period. She is also working on NAD+ and TFEB in AD. She was the 2025 recipient of the prestigious nasjonalforeningen for folkehelsen postdoc fellowship (3.0 million NOK). During her postdoc period, she has identified a robust mitophagy inducer alpha-amyrin published as as COVER STORY in Advanced Science (The Mitochondrial Guardian α-Amyrin Mitigates Alzheimer’s Disease Pathology via Modulation of the DLK-SARM1-ULK1 Axis – PubMed) with anti-AD potential. She is pushing this forward aiming for clinical trials. She is also leading a urolithin A-based phase II RCT funded by the prestigious Alzheimer’s Association (NO-Age/AD clinical trials – NO-AD).
Hobbies: Exploring the world, Snorkelling, Hiking, Yoga, Belly dance

Tomás Schmauck-Medina, MSc Neuroscience (UCL, UK), Lab engineer (2020.10-2021.03), DPhil student (2021.04-2025.05), Postdoc Fellow (2025.06-present)
Email: tschmauck [at] gmail.com
Tomás is interested in the mechanisms of ageing and age-related neurodegenerative diseases. After his bachelor degree in Biomedicine he went to University College London (UCL) to study Neuroscience and worked on ageing in the laboratory of Professor Dame Linda Partridge. At UCL, he studied the neuroprotective role of GADD45 in ALS. In the Fang laboratory at the University of Oslo (UiO), he is interested in the mechanisms of ageing, autophagy, mitophagy, and how they impact neurodegeneration, with a focus on Alzheimer’s disease. He is using C. elegans, mice, and iPSCs in combination with CRISPR and super-resolution confocal microscopy techniques to address related questions. Schmauck-Medina had his oral defense (viva voce) entitled ‘ATG-18/WIPI2, NAD+, and fasting converge through autophagy in healthy ageing and Alzheimer’s disease’ on 29 April 2025. Based on a recent commissioned Nature Ageing review paper on dietary restriction and healthy ageing (Dietary restriction in aging and longevity – PubMed), his postdoc projects have expanded from continued exploration of ATG-18/WIPI2 in healthy longevity to a combination of dietary restriction and NAD+ in longevity and brain health.
Hobbies: Writing, debating, real-time strategy games

He-Ling Wang, DDS, PhD
Former Fang Lab DPhil Student (Dec 2020–Nov 2024); Postdoctoral Fellow (Nov 2024–Present)
Email: helingwang.med@gmail.com
He-Ling Wang earned her Bachelor’s degree in Medicine and Master’s degree in Oral Medicine from Jilin University, China, and is a licensed dentist in China. During her master’s training, she completed a one-year research internship at Okayama University, Japan, where she received training in microbiota research with a particular focus on microbiota-associated diseases.Wang joined the Fang Lab at the University of Oslo (UiO) in December 2020 as a doctoral researcher. Her PhD investigated the molecular mechanisms underlying Alzheimer’s disease, with particular emphasis on APOE4, NAD⁺ metabolism, and mitochondrial quality control. She successfully defended her doctoral thesis, Pharmacological and Behavioural Interventions to Slow Down Alzheimer’s Disease: Focusing on Mitochondrial Quality Control at the Molecular Level, on 20 November 2024. Building on her doctoral research, Wang now continues her mechanistic studies of Alzheimer’s disease while expanding her research to investigate the biological processes underlying the transition from healthy brain aging to Alzheimer’s disease through experimental and longitudinal cohort studies. She also explores how the gut microbiota–brain axis influences brain aging and neurodegeneration. In 2025, Wang was awarded the prestigious Nasjonalforeningen for folkehelsen Postdoctoral Fellowship (3.0 million NOK), supporting her research on the molecular and population-level determinants of brain aging and Alzheimer’s disease. Among many publications in the Fang lab, a recent one was a commissioned review paper on NAD+ for Nature Ageing (Emerging strategies, applications and challenges of targeting NAD+ in the clinic – PubMed), jointed with Janet Zhang and other co-authors.
Hobbies: Outside the laboratory, Wang enjoys traveling and creative pursuits, including songwriting and illustration, ranging from scientific figures to everyday sketches.

Ping-Jie Wang, MSc, DPhil student, ZhengZhou University (2021.09 -2025.05 co-mentored with Prof. Guo-bing Chen), postdoc fellow (2025.06 – present, co-mentored with Prof. Guo-bing Chen in JI-nan University)
Email: wpj0405 [at] 163.com
Ping-jie received her Master’s degree in Neurobiology from Jinan University’s Guangdong-Hong Kong-Macao Institute of Central Nervous System (CNS) Regeneration (GHMICR) under Professor Kwok-Fai So. She is mainly engaged in research on the mechanism of adiponectin-mediated exercise to improve symptoms of depression. She is very interested in the mechanism of neurodegenerative diseases, and is carrying out her PhD project in the Fang laboratory, where she will mainly study the mechanism of Alzheimer’s disease, focusing on ULK1, NAD+ and mitophagy. Wang had her oral defense (viva voce) entitled ‘自噬激酶ULK1对衰老及其相关疾病的影响研究 (Roles of ULK1 in ageing and related diseases)’ on 17 May 2025. During her postdoc period, she is leading several big projects, including ULK1 in longevity and in inhibiting depression.
Hobbies: Hiking, jogging, yoga.

Sifang Liao, Ph.D. (Stockholm University), Postdoc Fellow (2022.11-present)
Email: sifang.liao [at ]medisin.uio.no
Sifang obtained his doctoral degree from the Zoology Department of Stockholm University under the supervision of professor Dick Nässel in 2018. During his Ph.D. studies, he became interested in examining the role of insulin signaling pathways and environmental conditions on aging in the fruit fly, Drosophila melanogaster. After his doctorate, he worked as a postdoc in the Department of Neuroscience, Functional Pharmacology, Uppsala University, under the supervision of Helgi Schiöth for two years. There he studied the effects of environmental pollutants on neuroendocrine function. As a researcher, he worked in Tor Erick’s lab to screen tumor microenvironment factors affecting tumor growth. Currently, he is a postdoc in the Fang laboratory, where he collaborates with Professor Nilsson at the Karolinska Institute, Sweden, to study the effects of mitophagy on inflammation in Alzheimer’s disease, with mice as the model organism. His major project is to investigate roles of a key mitophagy protein TBK1 in coordinating mitophagy and inflammation in AD.
Hobbies: Badminton, Ping-Pong, swimming, hiking.

Johannes Frank, ERASMUS student in the Fang lab (2019.06-2020.01), MSc (2020.09-2023.08 student at the University of Vienna), DPhil student (2023.09 – present)
Email: jfrank0990 [at] gmail.com
Mr. Johannes Frank was an exchange student at the Fang lab for his bachelor’s degree at the University of Applied Sciences in Krems, Austria. He wrote his bachelor’s thesis about research undertaken during his six months internship in the Fang group. During his internship he was involved in studying the anti-aging effect of NAD+ precursors and mitophagy inducers on premature aging, especially in Werner syndrome, using the model organisms Drosophila melanogaster and C. elegans. Currently he is taking a master’s degree in Molecular Biology with a major in Neuroscience at the University of Vienna, Austria. Besides his Master Program, he is working on a collaborative project in the Zimmer Group at the Research Institute of Molecular Pathology in Vienna. For this Project he analyses the sleeping behavior of C. elegans Alzheimer’s models. His PhD project is focused on ferroptosis, including how it changes in a lifetime continuum, and how it changes in and then contributes to AD. His PhD fellowship is sponsored by the Marie Skłodowska-Curie Actions (MSCA) Doctoral Network NADIS (The NAD⁺ International Student Training Network – NADIS) which enables him to do two secondments including in Prof. Dr. Riekelt Houtkooper lab (Amsterdam University Medical Centers, The Netherlands) and Dr. Michela Deleidi lab (Institut Imagine Paris, France). These secondment experiences have greatly broadened his laboratory skills and consolidated his team work skills. His recent publication is a co-authored paper in Alzheimer&Dementia (in press, 2026).
Hobbies: skiing, fencing, weight training.

Beatriz Escobar Doncel, Internship Student (2021.08 to 2022.08), DPhil student of UiO (2023.10-present)
Email:
escobardoncel.beatriz [at] gmail.com
Beatriz got her bachelor degree in “Health Biology” at the University of Alcalá (UAH) in Spain, where she learnt the best of medicine and biology together. In those years, she did several internships to learn about neurodegenerative and cardiovascular diseases in the aging field. She had just finished her MSc in “Therapeutic Targets in Cell Signaling: Research and Development”. Thanks to that she has been studying the proteostasis modifications in a premature aging disease called Hutchinson-Gilford Progeria Syndrome (HGPS). During her studies, she has dreamt about researching aging to unravel the molecular mechanisms of this process and make people have a better quality of life. She is doing a PhD in the Fang lab on mechanisms of ageing and Alzheimer’s disease (AD), and is actively involved in the development of drug candidates against AD and in prompting healthy ageing. She has several publications during her PhD period, including two (co-)first author papers in NPJ Ageing (Two-photon in vivo imaging reveals cell type-specific mitophagy dynamic changes in mouse somatosensory cortex during aging – PubMed) and Brain (Loss of REST associated with Alzheimer’s disease pathology is ameliorated by NAD – PubMed), respectively.
Hobbies: cooking, basketball, reading, series and traveling.

Jun-yu Tan, DPhil student, Jinan University (Guang-zhou), China (2024.09 – present, Primary mentor Prof. Guo-bing Chen)
Email: junyutan94 [at] 163.com
Jun-yu obtained his Master’s degree in Pathology and Pathophysiology from Shantou University Medical College in 2020, with a research focus on the molecular mechanisms of breast cancer invasion and metastasis. In 2020, he worked in the Department of Laboratory Medicine and Central Laboratory at the Third People’s Hospital of Huizhou City. He is currently pursuing his PhD in Basic Medical Sciences at Jinan University as a joint PhD student under the supervision of Prof. Guo-bing Chen and Prof. Evandro F. Fang, focusing on the mechanisms of and interventions against Alzheimer’s disease, particularly on fasting (TRF/CR), neuro-immune interactions, ApoE4, NAD+, and autophagy/lipophagy.
Hobbies: Ping-Pong, Badminton

Beatriz Perez Piccolo, MSc student, FMRP-USP, Brazil (2026.04–present)
Email: bepiccolo@usp.br
Beatriz graduated in 2024 with a degree in Biological Sciences from the University of São Paulo (USP), Brazil. As an undergraduate, under the supervision of Prof. Dr. Wagner Ferreira dos Santos, she investigated the bioactivity of the South American spider Parawixia bistriata venom, focusing on its potential neuroprotective effects. She also joined the laboratory of Prof. Dr. Tara Pukala at the University of Adelaide, Australia, where she studied the anti-amyloid properties of venom-derived compounds. Currently, Beatriz is pursuing a Master’s degree in Biochemistry at the Ribeirão Preto Medical School (FMRP-USP), studying the effects of spider venom derivatives in Alzheimer’s disease (AD) models. As a visiting researcher in the Evandro Fang Lab at the University of Oslo, she aims to deepen her understanding of ageing and AD mechanisms, contribute to ongoing projects, and integrate these insights into her Master’s project. She is passionate about neuroscience and the medical applications of natural compounds.
Hobbies: yoga, horse riding, exploring nature – and collecting spiders.

Yu-Han Chen, DPhil student, Jinan University (Guang-zhou), China (2025.09 – present, co-mentored with Prof. Guo-bing Chen)
Email:chenyu22900442@163.com
Yu-Han Chen was awarded a Master of Medical Science degree from Yunnan University of Chinese Medicine in 2025. Her research focused on the immunomodulatory molecular mechanisms of Cepharanthine in treating pancreatic cancer. Currently, she is pursuing her PhD in Basic Medical Sciences as a joint PhD candidate at the School of Basic Medicine, Jinan University, under the supervision of Prof. Guo-bing Chen and Prof. Evandro F. Fang. Her primary research focus encompasses the mechanisms of and interventions against Alzheimer’s disease, particularly caloric restriction (CR), neuro-immune interactions, ApoE4, NAD+, and autophagy/lipophagy.
Hobbies: piano, badminton, travel, and reading  

Ole Peter Nordby, MSc student, UiO , (2026.4 – present) 
Email: olepno@student.ibv.uio.no
Ole Peter Nordby holds degrees in theology from the University of Oslo (UiO) and economics from the BI Norwegian Business School. Currently, he is a Master’s student in the Cell Biology, Physiology, and Neuroscience programme offered by the Department of Biosciences of UiO. In his Master’s thesis, Ole will investigate how glycations damage mitochondrial function using C. elegans as a model organism. He aims to determine whether this damage can be mitigated by inducing mitophagy through interventions with Urolithin A and NAD+. Glycation damage occurs when sugars and/or reactive dicarbonyls react with the amino acid residues lysine (K) and arginine (R), leading to irreversible adducts and cross-links. The accumulation of these modifications is linked to a range of age-related diseases, including late-stage diabetes complications and neurodegenerative disorders, positioning glycation as a critical factor in the aging process. Ole’s research holds the potential to shed light on therapeutic interventions that could alleviate mitochondrial dysfunction, providing avenues for addressing age-related health challenges.
Hobbies: Reading and writing local history and maintaining a community garden with its hut.

Alexander D. Carlsson, master’s student, Lund University, Sweden (2026.04-present)
Email: al0436ca-s@student.lu.se
Alexander encountered age-related diseases at a young age with a grandma with Alzheimer’s Disease (AD) and a grandpa with very severe osteoarthritis. Wanting to free the world of such age-related ailments, he decided at age 12 to devote his life to understanding the biological processes behind ageing and how to reverse it. Following this path, he graduated in 2025 from Lund University with a bachelor’s degree in biomedicine, having worked in labs during his bachelor’s that focused both on the prion-like propagation of amyloid beta in AD under Prof. Dr. Gunnar Gouras and epigenetic rejuvenation in fibroblasts using reprogramming factors under Dr. Henrik Ahlenius. Currently, Alexander is pursuing a master’s degree in biomedicine at Lund University. In the Fang Lab of the University of Oslo, Alexander is deepening his knowledge in the field of molecular ageing and brain resilience by working on the underlying molecular mechanisms under the supervision of Dr. He-Ling Wang.
Hobbies: Carpentry; DIY; triathlon training; cooking; weightlifting
Contributions: a glimpse of the Fang lab area (credit Alexander D. Carlsson)

Longjun PU, joint postdoc fellow with Prof. Chang-Chun CHEN (Umeå University, Sweden) (2026.09 – present)
Longjun Pu earned his PhD from Umeå University under the supervision of Professor Changchun Chen. During his doctoral studies, he used the nematode Caenorhabditis elegans as a model system to investigate the molecular basis of sensory behaviors and to elucidate the mechanisms that enable organisms to respond to environmental stress while maintaining homeostasis. A major achievement of his PhD research was the establishment of a comprehensive GPCR mutant library in C. elegans using CRISPR/Cas9 technology. Through this effort, more than 1,600 GPCR genes were precisely disrupted, creating a valuable resource for both his own research and the broader C. elegans community. This library provides a powerful platform for accelerating investigations into GPCR signaling across a wide range of biological processes. Following his doctoral training, Longjun has continued to explore the molecular mechanisms that govern organismal homeostasis, with a particular focus on aging. As a postdoctoral researcher in the Fang Lab, he investigates how evolutionarily conserved molecular pathways regulate aging and contribute to aging-related disease progression. His research aims to uncover novel biological mechanisms and identify potential therapeutic targets for age-related diseases. In recognition of his research achievements and potential, he was awarded the prestigious International Postdoc Grant from the Swedish Research Council in 2024.
Hobbies: Basketball, cycling, and nature exploration.

Juha Yoon, exchange summer student (University of Ulsan College of Medicine / UUCM, Seoul, Korea) (2026.07 – 2026.08)
Email : yoonjuha1213@gmail.com
Juha is an M.D. candidate at the University of Ulsan College of Medicine (UUCM) in South Korea. Having completed core clinical clerkships at Asan Medical Center, she actively seeks diverse international clinical and research experiences, including a surgical observer-ship at Stanford University (June–July 2026). Interested in bridging clinical observations with fundamental biological research, she joined the Evandro Fang lab to investigate the molecular mechanisms of aging using the roundworm C. elegans. Her daily mentor is Postdoc fellow Dr. Tomás Schmauck-Medina. Outside of research, she has held student leadership roles and regularly participates in community medical volunteer services.
Hobbies : dance, traveling

Noah Sidali-Wahlstrøm, MSc student, UiO (2026.01 – present) 
Email: noahsw25 [at] icloud.com 
Noah is a second-year masters student in Bioscience, specializing in biochemistry and molecular biology at the University of Oslo. Noah graduated with a bachelors degree in Bioscience at UiO whilst simultaneously working as a research assistant at the Fang lab, prompting him to return to the Fang lab for his masters thesis. He is interested in molecular and biochemical mechanisms that control biological and medically relevant processes, like the effects of iron homeostasis/ferroptosis on aging, mitophagy and mitochondrial ROS. Noah is working with Johannes Frank, using the common and powerful model organism C. elegans
Hobbies: Football, snowboarding, music, and video games.

Junping Pan, PhD (Jinan University, China), Postdoc Fellow (2022.09 – present)
Email: panjunpingjnu319 [at] 163.com
Junping obtained his Master’s degree from the Neuropharmacology Department of Jinan University under the supervision of Professor Huanmin Luo in 2018. He is mainly engaged in research on how methyl 3,4-dihydroxybenzoate induces neural stem cells to differentiate into cholinergic neurons in vitro. Junping worked in the Neurosurgery Department of Guangdong Women and Children’s Medical Center in 2019. He received doctoral degree in immunology from the School of Basic Medical Sciences, Jinan University under the supervision of Professor Guobing Chen and Evandro F. Fang in 2022.  His PhD project was focused on ULK1 abrogation of memory loss and pathologies in 5XFAD and hTau.P301S murine models of Alzheimer’s disease. In his postdoc programme, he is continuing to study the mechanics of ULK1 in AD and the role of ULK1 in healthy aging. He is also studying the role of traditional Chinese medicine in inducing mitophagy to improve AD. Pan had his oral defense (viva voce) entitled ‘ULK1 improves learning and memory impairment in Alzheimer’s disease and its mechanism’ in 2022. He was the 2024 recipient of the prestigious nasjonalforeningen for folkehelsen postdoc fellowship. His recent publication was a COVER STORY of the May 2026 Issue in Nature Ageing (Reduced ULK1 links impaired autophagy and mitophagy to Alzheimer’s disease pathology – PubMed) with editorial in Nature Reviews Neurology (Autophagy protein links ageing and Alzheimer disease – PubMed). His postdocs works are mainly focused on ULK1 and its unknown roles in neuroprotection.
Hobbies: Hiking, boxing, swimming, gourmet cooking.

Alice Ruixue Ai, former Fang lab Dr. Philos. (Doctor Philosophiae) (2021.05-2023.09); Postdoc Fellow (2023.10-present)
Email: ruixue.ai [at] outlook.com
Alice Ruixue Ai studied in oral medicine from Sichuan University, China. During her Masters period, she investigated microenvironmental regulation of the progression of potentially malignant oral disorders towards malignancy; she published four papers in international peer-reviewed journals during this time. With the Fang lab and their collaborators, she is applying artificial intelligence to the screening and designing of drug candidates for ageing and Alzheimer’s disease. She is also very interested in studying the role of mRNA splicing in NAD+-mitophagy axis and age-dependent mitophagy changes in AD. Ai had her oral defense (viva voce) entitled ‘Novel mechanisms of NAD+-dependent inhibition of Alzheimer’s disease and AI-based technologies in related mechanistic studies and drug discovery’ on 25 September 2023.
Hobbies: Traditional Chinese painting and yoga.